Casirivimab and Imdevimab for Early Asymptomatic SARS-CoV-2 Infection, Hypothermia vs Normothermia for Cardiogenic Shock and Extracorporeal Membrane Oxygenation, Familial Idiopathic Dilated Cardiomyopathy, and more
- Author
- American Medical Association
- Published
- Tue 01 Feb 2022
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.23161
Editor’s Summary by Linda Brubaker, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the February 1, 2022, issue.
